Analysts forecast that Vitamin Shoppe Inc (NYSE:VSI) will report earnings of ($0.24) per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Vitamin Shoppe’s earnings, with the highest EPS estimate coming in at ($0.04) and the lowest estimate coming in at ($0.35). Vitamin Shoppe reported earnings of $0.36 per share in the same quarter last year, which would indicate a negative year over year growth rate of 166.7%. The firm is expected to issue its next earnings results on Wednesday, March 7th.
According to Zacks, analysts expect that Vitamin Shoppe will report full year earnings of $0.34 per share for the current fiscal year, with EPS estimates ranging from $0.22 to $0.52. For the next fiscal year, analysts anticipate that the company will report earnings of $0.31 per share, with EPS estimates ranging from $0.20 to $0.60. Zacks’ EPS averages are an average based on a survey of analysts that follow Vitamin Shoppe.
A number of brokerages recently commented on VSI. Barclays dropped their price target on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Morgan Stanley dropped their price target on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. Finally, Zacks Investment Research raised Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Sunday, January 21st. Three research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $5.00.
Large investors have recently modified their holdings of the company. Macquarie Group Ltd. bought a new position in shares of Vitamin Shoppe during the third quarter valued at $101,000. Crossmark Global Holdings Inc. increased its holdings in shares of Vitamin Shoppe by 122.8% during the fourth quarter. Crossmark Global Holdings Inc. now owns 31,320 shares of the specialty retailer’s stock valued at $138,000 after acquiring an additional 17,260 shares in the last quarter. UBS Asset Management Americas Inc. increased its holdings in shares of Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after acquiring an additional 11,929 shares in the last quarter. Dynamic Technology Lab Private Ltd increased its holdings in shares of Vitamin Shoppe by 72.7% during the second quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock valued at $207,000 after acquiring an additional 7,478 shares in the last quarter. Finally, Trexquant Investment LP bought a new position in shares of Vitamin Shoppe during the third quarter valued at $243,000. Hedge funds and other institutional investors own 98.96% of the company’s stock.
Shares of Vitamin Shoppe (NYSE:VSI) opened at $3.75 on Monday. Vitamin Shoppe has a 52 week low of $2.95 and a 52 week high of $23.25. The company has a market capitalization of $89.92, a price-to-earnings ratio of -0.35 and a beta of 0.59. The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59.
WARNING: “Zacks: Analysts Anticipate Vitamin Shoppe Inc (VSI) Will Announce Earnings of -$0.24 Per Share” was originally published by American Banking News and is the property of of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2018/02/12/zacks-analysts-anticipate-vitamin-shoppe-inc-vsi-will-announce-earnings-of-0-24-per-share.html.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.